13 results
10-K/A
2022 FY
CADL
Candel Therapeutics Inc
1 May 23
Annual report (amended)
8:01am
executive officers with a strong link to our long-term performance, create an ownership culture and help to align the interests of our executive officers
DEF 14A
CADL
Candel Therapeutics Inc
2 Sep 22
Definitive proxy
8:30am
to contribute positively to the collaborative culture among board members, and their knowledge of our business and understanding of the competitive landscape … our executive officers with a strong link to our long-term performance, create an ownership culture and help to align the interests of our executive
10-K
2021 FY
CADL
Candel Therapeutics Inc
29 Mar 22
Annual report
8:46am
-term performance, create an ownership culture and help to align the interests of our executive officers and our stockholders. In addition, we believe
424B4
shxc3rmefeb8uvnk
28 Jul 21
Prospectus supplement with pricing info
4:02pm
S-1/A
EX-10.9
lbvt eadzddxyh
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
dtvgj52g
16 Jul 21
IPO registration (amended)
6:07am
S-1
g5eo ww53u6elu
25 Jun 21
IPO registration
5:28pm
S-1
EX-10.8
vc34n
25 Jun 21
IPO registration
5:28pm
S-1
EX-10.9
earjkt0t re7rwki
25 Jun 21
IPO registration
5:28pm
DRS/A
2y42b0 4spz
31 Mar 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next